Cigdem Ichedef
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cigdem Ichedef has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Serap Teksöz
Department of Nuclear Applications, Institute of Nuclear Sciences, Ege University, İzmir, Turkey
14 shared publications - Ayfer Yurt Kilcar
Institute of Nuclear Sciences, Ege University, Bornova, Izmir, 35100, Türkiye
11 shared publications - Fazilet Zumrut Biber Muftuler
Department of Nuclear Applications, Institute of Nuclear Sciences, Ege University, İzmir, Turkey
9 shared publications Perihan Unak
Ege University
6 shared publicationsPerihan Ünak
Institute of Nuclear Sciences, Ege University, 35100 Izmir, Turkey
5 shared publicationsE. Ilker Medine
Department of Nuclear Applications, Institute of Nuclear Sciences Ege University, Bornova, 35100 İzmir, Turkey
3 shared publications
Latest Publications
- 30 March 2026
- Published by Celal Bayar University Journal of Science in Celal Bayar Üniversitesi Fen Bilimleri Dergisi
- Vol. 22 (1) , 60-66
Production and Characterization of Ag-Doped Multilayer Polyaniline Thin Films by Sol- Gel Method
Recently, studies on thin films have attracted increasing attention from scientists. Polyaniline thin films (PANI), which are among the thin films, are preferred for various applications due to their electrical conductivity, environmental stability, thermal stability and doping properties. PANI are used in many areas including supercapacitors, sensors, electronic devices, drug delivery systems. In this study, monolayer, five-layer, Ag-doped, and HCI-doped PANI thin films were synthesized by sol-gel method and coated on glass substrate via spin coating technique. The chemical, electrical, and morphological properties of glass substrates coated with polyaniline thin film were investigated. The effects of layer number and Ag addition on the characteristics of the PANI thin films were evaluated. SEM analysis revealed that PANI thin films possess a porous structure, and Ag doping improves surface homogeneity. SEM analysis proved that PANI thin films have a porous structure and Ag doping improves the surface morphology. Current–voltage (I–V) measurements were performed to determine the electrical properties of the films. The results showed that the conductivity of the five-layer PANI thin film was 25.75 times higher than that of the monolayer film. This finding suggests that Ag doping alters the charge transport mechanisms in PANI thin films and warrants further investigation.
- 30 March 2026
- Published by Celal Bayar University Journal of Science in Celal Bayar Üniversitesi Fen Bilimleri Dergisi
- Vol. 22 (1) , 60-66
Production and Characterization of Ag-Doped Multilayer Polyaniline Thin Films by Sol- Gel Method
Recently, studies on thin films have attracted increasing attention from scientists. Polyaniline thin films (PANI), which are among the thin films, are preferred for various applications due to their electrical conductivity, environmental stability, thermal stability and doping properties. PANI are used in many areas including supercapacitors, sensors, electronic devices, drug delivery systems. In this study, monolayer, five-layer, Ag-doped, and HCI-doped PANI thin films were synthesized by sol-gel method and coated on glass substrate via spin coating technique. The chemical, electrical, and morphological properties of glass substrates coated with polyaniline thin film were investigated. The effects of layer number and Ag addition on the characteristics of the PANI thin films were evaluated. SEM analysis revealed that PANI thin films possess a porous structure, and Ag doping improves surface homogeneity. SEM analysis proved that PANI thin films have a porous structure and Ag doping improves the surface morphology. Current–voltage (I–V) measurements were performed to determine the electrical properties of the films. The results showed that the conductivity of the five-layer PANI thin film was 25.75 times higher than that of the monolayer film. This finding suggests that Ag doping alters the charge transport mechanisms in PANI thin films and warrants further investigation.
- 1 March 2023
- Published by Galenos Yayinevi in Nuclear Medicine Seminars
- Vol. 9 (1) , 58-64
Characteristics of Radioisotope Generators and Mo-99/Tc-99m Generator
- 1 March 2023
- Published by Galenos Yayinevi in Nuclear Medicine Seminars
- Vol. 9 (1) , 58-64
Characteristics of Radioisotope Generators and Mo-99/Tc-99m Generator
- 1 April 2021
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 263
Design of 99mTc radiolabeled gemcitabine polymeric nanoparticles as drug delivery system and in vivo evaluation
- 1 April 2021
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 263
Design of 99mTc radiolabeled gemcitabine polymeric nanoparticles as drug delivery system and in vivo evaluation
- 31 March 2021
- Published by Bentham Science Publishers Ltd. in Current Radiopharmaceuticals
- Vol. 14 (1) , 37-45
Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies
Backgorund: Superparamagnetic iron oxide nanoparticles (SPIONs) have been extensively used for targeted drug delivery systems due to their unique magnetic properties. Objective: In this study, it has been aimed to develop a novel targeted 99mTc radiolabeled polymeric drug delivery system for Gemcitabine (GEM). Methods: Gemcitabine, an anticancer agent, was encapsulated into polymer nanoparticles (PLGA) together with iron oxide nanoparticles via double emulsion technique and then labeled with 99mTc. SPIONs were synthesized by reduction–coprecipitation method and encapsulated with oleic acid for surface modification. Size distribution and the morphology of the synthesized nanoparticles were characterized by dynamic light scattering (DLS) and scanning electron microscopy (SEM), respectively. The radiolabeling yield of SPION-PLGAGEM nanoparticles was determined via Thin Layer Radio Chromatography (TLRC). Cytotoxicity of GEM loaded SPION-PLGA was investigated on MDA-MB-231 and MCF7 breast cancer cells in vitro. Results: SEM images displayed that the average size of the drug-free nanoparticles was 40 nm and the size of the drug-loaded nanoparticles was 50 nm. The diameter of nanoparticles was determined as 366.6 nm by DLS, while zeta potential was found as 29 mV. SPION was successfully coated with PLGA, which was confirmed by FTIR. GEM encapsulation efficiency of SPION-PLGA was calculated as 4±0.16% by means of HPLC. Radiolabeling yield of SPION-PLGA-GEM nanoparticles was determined as 97.8±1.75% via TLRC. Cytotoxicity of GEM loaded SPION-PLGA was investigated on MDA-MB-231 and MCF7 breast cancer cells. SPION-PLGA-GEM showed high uptake on MCF-7, while the incorporation rate was increased for both cell lines with external magnetic field application. Conclusion: 99mTc labeled SPION-PLGA nanoparticles loaded with GEM may overcome some of the obstacles in anti-cancer drug delivery because of their appropriate size, non-toxic, and superparamagnetic characteristics.
- 31 March 2021
- Published by Bentham Science Publishers Ltd. in Current Radiopharmaceuticals
- Vol. 14 (1) , 37-45
Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies
Backgorund: Superparamagnetic iron oxide nanoparticles (SPIONs) have been extensively used for targeted drug delivery systems due to their unique magnetic properties. Objective: In this study, it has been aimed to develop a novel targeted 99mTc radiolabeled polymeric drug delivery system for Gemcitabine (GEM). Methods: Gemcitabine, an anticancer agent, was encapsulated into polymer nanoparticles (PLGA) together with iron oxide nanoparticles via double emulsion technique and then labeled with 99mTc. SPIONs were synthesized by reduction–coprecipitation method and encapsulated with oleic acid for surface modification. Size distribution and the morphology of the synthesized nanoparticles were characterized by dynamic light scattering (DLS) and scanning electron microscopy (SEM), respectively. The radiolabeling yield of SPION-PLGAGEM nanoparticles was determined via Thin Layer Radio Chromatography (TLRC). Cytotoxicity of GEM loaded SPION-PLGA was investigated on MDA-MB-231 and MCF7 breast cancer cells in vitro. Results: SEM images displayed that the average size of the drug-free nanoparticles was 40 nm and the size of the drug-loaded nanoparticles was 50 nm. The diameter of nanoparticles was determined as 366.6 nm by DLS, while zeta potential was found as 29 mV. SPION was successfully coated with PLGA, which was confirmed by FTIR. GEM encapsulation efficiency of SPION-PLGA was calculated as 4±0.16% by means of HPLC. Radiolabeling yield of SPION-PLGA-GEM nanoparticles was determined as 97.8±1.75% via TLRC. Cytotoxicity of GEM loaded SPION-PLGA was investigated on MDA-MB-231 and MCF7 breast cancer cells. SPION-PLGA-GEM showed high uptake on MCF-7, while the incorporation rate was increased for both cell lines with external magnetic field application. Conclusion: 99mTc labeled SPION-PLGA nanoparticles loaded with GEM may overcome some of the obstacles in anti-cancer drug delivery because of their appropriate size, non-toxic, and superparamagnetic characteristics.
- 14 September 2020
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 20 (13) , 1626-1634
Biocompatible Delivery System for Metformin: Characterization, Radiolabeling and In Vitro Studies
Background: In recent years, the uses of nanotechnology in medicine have an increasing potential as an effective nanocarrier system. These systems are improved with the purpose of maximizing therapeutic activity and minimizing undesirable side-effects. Moreover, radiolabeled nanoparticles can be used as agents for diagnosis and therapeutic purposes in clinical applications. They have three main components: the core, the targeting biomolecule, and the radionuclide. Objective: It is aimed to synthesize Metformin (MET) loaded Solid Lipid Nanoparticles (MET-SLN) and radiolabeled with technetium-99m tricarbonyl core. Methods: The structure of synthesized nanoparticles was characterized by Fourier Transform Infrared Spectroscopy (FTIR). The particle size and morphology of nanoparticles were examined by Dynamic Light Scattering (DLS), and Scanning Electron Microscope (SEM). Quality control studies of radiolabeled MET-SLN [99mTc(CO)3-MET-SLN] were performed by High-Performance Liquid Radiochromatography (HPLRC) and Thin Layer Radiochromatography (TLRC). Results: The radiolabeling yield of [99mTc(CO)3-MET-SLN] was found to be 88%. In vitro studies have been performed on cancer lines(MCF7, MDA-MD-231 breast, and HEPG2 liver cancer cells) to determine the biological behavior of 99mTc(CO)3-MET-SLNs. Conclusion: The results showed that higher uptake values were observed on estrogen-positive MCF7 breast cancer cell line according to estrogen negative MDA-MB-231 breast cancer and HEPG2 liver cancer cell lines.
- 14 September 2020
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 20 (13) , 1626-1634
Biocompatible Delivery System for Metformin: Characterization, Radiolabeling and In Vitro Studies
Background: In recent years, the uses of nanotechnology in medicine have an increasing potential as an effective nanocarrier system. These systems are improved with the purpose of maximizing therapeutic activity and minimizing undesirable side-effects. Moreover, radiolabeled nanoparticles can be used as agents for diagnosis and therapeutic purposes in clinical applications. They have three main components: the core, the targeting biomolecule, and the radionuclide. Objective: It is aimed to synthesize Metformin (MET) loaded Solid Lipid Nanoparticles (MET-SLN) and radiolabeled with technetium-99m tricarbonyl core. Methods: The structure of synthesized nanoparticles was characterized by Fourier Transform Infrared Spectroscopy (FTIR). The particle size and morphology of nanoparticles were examined by Dynamic Light Scattering (DLS), and Scanning Electron Microscope (SEM). Quality control studies of radiolabeled MET-SLN [99mTc(CO)3-MET-SLN] were performed by High-Performance Liquid Radiochromatography (HPLRC) and Thin Layer Radiochromatography (TLRC). Results: The radiolabeling yield of [99mTc(CO)3-MET-SLN] was found to be 88%. In vitro studies have been performed on cancer lines(MCF7, MDA-MD-231 breast, and HEPG2 liver cancer cells) to determine the biological behavior of 99mTc(CO)3-MET-SLNs. Conclusion: The results showed that higher uptake values were observed on estrogen-positive MCF7 breast cancer cell line according to estrogen negative MDA-MB-231 breast cancer and HEPG2 liver cancer cell lines.
- 9 June 2020
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 46 (7) , 1108-1113
Preparation of technetium-99m labeled ibuprofen by direct route and technetium-99m tricarbonyl route: a comparison of in vivo behaviors
In the current study, ibuprofen (ibu) which is a non-steroidal anti-inflammatory drug (NSAID) was radiolabeled with 99mTc using two different methods: stannous chloride method (direct route) and technetium-99m tricarbonyl [99mTc(CO)3]+ route. Thus, it’s aimed to investigate the radiolabeling potential of ibu for inflammation detection and to monitor if there is any difference in in vivo distribution depending on the radiolabeling route. Quality control studies of both radiolabeled ibu were performed by radiochromatographic methods (Thin Layer Liquid Radio Chromatography and High Performance Liquid Radio Chromatography). Radiolabeling yields of 99mTc-ibu and 99mTc(CO)3-ibu were determined as 99.05 ± 0.83% and 91.79 ± 3.30% (n = 5), respectively. Experimental lipophilicities of both radiolabeled ibu were determined. The biological behaviour of both radiolabeled ibu was investigated in healthy Albino Wistar male rats by in vivo biodistribution studies. It was seen that both radiolabeled ibuprofen showed renal excretion while organ uptakes of 99mTc-ibu and 99mTc(CO)3-ibu differ against time.
- 9 June 2020
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 46 (7) , 1108-1113
Preparation of technetium-99m labeled ibuprofen by direct route and technetium-99m tricarbonyl route: a comparison of in vivo behaviors
In the current study, ibuprofen (ibu) which is a non-steroidal anti-inflammatory drug (NSAID) was radiolabeled with 99mTc using two different methods: stannous chloride method (direct route) and technetium-99m tricarbonyl [99mTc(CO)3]+ route. Thus, it’s aimed to investigate the radiolabeling potential of ibu for inflammation detection and to monitor if there is any difference in in vivo distribution depending on the radiolabeling route. Quality control studies of both radiolabeled ibu were performed by radiochromatographic methods (Thin Layer Liquid Radio Chromatography and High Performance Liquid Radio Chromatography). Radiolabeling yields of 99mTc-ibu and 99mTc(CO)3-ibu were determined as 99.05 ± 0.83% and 91.79 ± 3.30% (n = 5), respectively. Experimental lipophilicities of both radiolabeled ibu were determined. The biological behaviour of both radiolabeled ibu was investigated in healthy Albino Wistar male rats by in vivo biodistribution studies. It was seen that both radiolabeled ibuprofen showed renal excretion while organ uptakes of 99mTc-ibu and 99mTc(CO)3-ibu differ against time.
- 17 October 2019
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 19 (11) , 1382-1387
Evaluation of New 99mTc(CO)3 + Radiolabeled Glycylglycine In Vivo
Background: Peptide-based agents are used in molecular imaging due to their unique properties, such as rapid clearance from the circulation, high affinity and target selectivity. Many of the radiolabeled peptides have been clinically experienced with diagnostic accuracy. The aim of this study was to investigate in vivo biological behavior of [99mTc(CO)3(H2O)3]+ radiolabeled glycylglycine (GlyGly). Methods: Glycylglycine was radiolabeled with a high radiolabeling yield of 94.69±2%, and quality control of the radiolabeling process was performed by thin layer radiochromatography (TLRC) and High-Performance Liquid Radiochromatography (HPLRC). Lipophilicity study for radiolabeled complex (99mTc(CO)3-Gly-Gly) was carried out using solvent extraction. The in vivo evaluation was performed by both biodistribution and SPECT imaging. Results: The high radiolabelling yield of 99mTc(CO)3-GlyGly was obtained and verified by TLRC and HPLRC as well. According to the in vivo results, SPECT images and biodistribution data are in good accordance. The excretion route from the body was both hepatobiliary and renal. Conclusion: This study shows that 99mTc(CO)3-GlyGly has the potential to be used as a peptide-based imaging agent. Further studies, 99mTc(CO)3-GlyGly can be performed on tumor-bearing animals.
- 17 October 2019
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 19 (11) , 1382-1387
Evaluation of New 99mTc(CO)3 + Radiolabeled Glycylglycine In Vivo
Background: Peptide-based agents are used in molecular imaging due to their unique properties, such as rapid clearance from the circulation, high affinity and target selectivity. Many of the radiolabeled peptides have been clinically experienced with diagnostic accuracy. The aim of this study was to investigate in vivo biological behavior of [99mTc(CO)3(H2O)3]+ radiolabeled glycylglycine (GlyGly). Methods: Glycylglycine was radiolabeled with a high radiolabeling yield of 94.69±2%, and quality control of the radiolabeling process was performed by thin layer radiochromatography (TLRC) and High-Performance Liquid Radiochromatography (HPLRC). Lipophilicity study for radiolabeled complex (99mTc(CO)3-Gly-Gly) was carried out using solvent extraction. The in vivo evaluation was performed by both biodistribution and SPECT imaging. Results: The high radiolabelling yield of 99mTc(CO)3-GlyGly was obtained and verified by TLRC and HPLRC as well. According to the in vivo results, SPECT images and biodistribution data are in good accordance. The excretion route from the body was both hepatobiliary and renal. Conclusion: This study shows that 99mTc(CO)3-GlyGly has the potential to be used as a peptide-based imaging agent. Further studies, 99mTc(CO)3-GlyGly can be performed on tumor-bearing animals.
- 1 September 2019
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 235, 121751
Bioevaluation of 99mTc(I) carbonyl-radiolabeled amino acid coated magnetic nanoparticles in vivo
- 1 September 2019
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 235, 121751
Bioevaluation of 99mTc(I) carbonyl-radiolabeled amino acid coated magnetic nanoparticles in vivo